NL-OMON31574WithdrawnNot Applicable
The Nanoduct study: a new sweat test system tested - The Nanoduct study
RIVM0 sites330 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Withdrawn
- Sponsor
- Enrollment
- 330
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 2 to 11 (—)
Inclusion Criteria
- •Newborns referred to the hospital for a sweat test after newborn screening. Children aged < 2 months with a suspected diagnosis of Cystic Fibrosis. informed consent has been obtained from the parents.
Exclusion Criteria
- •Newborns with severe eczema or sepsis (sweat test results are not reliable). Infants with meconiumileus. Informed consent cannot be obtained.
Investigators
Similar Trials
Recruiting
Not Applicable
Clinical evaluation of a new sweat test system in the diagnosis of cystic fibrosis after newborn screening1001567410010613Cystic FibrosisNL-OMON32874Atrium Medisch Centrum100
Not yet recruiting
Phase 2
A study to test the benefits of the Ayurvedic Proprietary Medicine Product on Dental HealthCTRI/2023/02/050139nilever Industries Pvt Ltd
Completed
Not Applicable
A study to test the benefits of the Product on dental problemsCTRI/2022/02/040692nilever Industries Pvt Ltd193
Not yet recruiting
Not Applicable
A study to test the benefits of the Product on Dental HealthCTRI/2023/02/049984nilever Industries Pvt Ltd
Completed
Phase 2
Study for hair growth and hair fallCTRI/2022/09/045239Monkey Creations Inc MCI54